Explore CSafe Resources

CSafe Global Makes the Main Deck an Option
CSafe RKNs approved for transport on main decks of narrow-bodied freighters.

Read More
CSafe hosts grand opening for new, larger service center in Puerto Rico and offers disaster relief for earthquake victims
CSafe Global has once again expanded their facility in San Juan and hosted a grand opening celebration for customers. With a large contingent of employees on the island, the organization used the opportunity to raise and donate funds to support residents displaced by the ongoing earthquakes.

Read More
CSafe expands service center in South Korea for active temperature-controlled containers
CSafe Global announces the opening of a newly-expanded service center in Incheon. The company-owned facility will allow CSafe to enhance support and service for customers transporting temperature-sensitive products to and from South Korea, while additionally serving as an important gateway hub for the greater APAC region.

Read More
CSafe Global to present new Cell & Gene cold chain packaging solution at Phacilitate Leaders World
CSafe experts will be on hand to demonstrate the company’s Cell & Gene thermal shipping solution at the Phacilitate Leaders World conference in Miami January 21-24.

Read More
CSafe’s expansion continues with opening of new service center in Memphis to meet increasing demand for CSafe active containers
CSafe Global announces the opening of a new service center in Memphis to enhance support and service levels for the growing demand for CSafe containers from life-science customers and partners transporting temperature-sensitive healthcare products from the Mid-South region of the US.

Read More
CSafe expands cold chain offerings for the Cell and Gene Therapy market with launch of high-performing AcuTemp Plus Series of temperature-controlled packaging
CSafe Global recently expanded its passive packaging portfolio by launching the new and innovative AcuTemp Plus Series of solutions to address the temperature-controlled shipping needs of commercial pharmaceuticals, clinical trials, and emerging cell and gene therapies.

Read More